Squadron Capital Management »

Scynexis shares owned by Squadron Capital Management

Quarter-by-quarter ownership of Scynexis (SCYX) shares owned by Squadron Capital Management from 13F filings

Historical chart of Squadron Capital Management investment in Scynexis

Tip: Access up to 7 years of quarterly data

All positions including Scynexis held by Squadron Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Scynexis by Squadron Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $7.0M 7.6M 0.92

More positions owned by Squadron Capital Management

Relmada Therapeutics (RLMD)
Cogent Biosciences (COGT)
Kalvista Pharmaceuticals (KALV)
Kodiak Sciences (KOD)
Abivax Sa Sponsored Ads (ABVX)
Edgewise Therapeutics (EWTX)
Zentalis Pharmaceuticals (ZNTL)
Nektar Therapeutics Com New (NKTR)
Adlai Nortye Sponsored Ads (ANL)
Relay Therapeutics (RLAY)
Maze Therapeatics (MAZE)
Ideaya Biosciences (IDYA)
Scynexis Com New (SCYX)
C4 Therapeutics Com Stk (CCCC)
Inhibikase Therapeutics Com New (IKT)

View all positions for Squadron Capital Management

Top funds holding Scynexis

Squadron Capital Management
Dr. Jeffrey R. Jay, M.D.
Avidity Partners Management
Kingdon Capital Management
Empery Asset Management
Vanguard Group
Vanguard Capital Management
DAFNA Capital Management
Acadian Asset Management
Millennium Management
Geode Capital Management
BlackRock
Vanguard Fiduciary Trust
Yakira Capital Management
Renaissance Technologies

View all funds holding Scynexis